Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ilya Okun

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Journal of Alzheimer'S Disease : JAD|May 28, 2016
AVN-101: A Multi-Target Drug Candidate for the Treatment of CNS DisordersAlexandre V Ivachtchenko, Yan Lavrovsky, Ilya Okun
Journal of Biomolecular Screening|July 5, 2002
Serotonin antagonist profiling on 5HT2A and 5HT2C receptors by nonequilibrium intracellular calcium response using an automated flow-through fluorescence analysis system, HT-PS 100Gregory Kaler, Michael Otto, Alex Okun, et al.
Anti-Cancer Agents in Medicinal Chemistry|April 9, 2008
Caspase activity modulators as anticancer agentsIlya Okun, Konstantin V Balakin, Sergey E Tkachenko, et al.
Bioorganic & Medicinal Chemistry|June 22, 2013
Synthesis of substituted diphenyl sulfones and their structure-activity relationship with the antagonism of 5-НТ6 receptorsAlexandre Ivachtchenko, Elena Golovina, Madina Kadieva, et al.
Journal of Biomolecular Screening|July 18, 2006
Screening for caspase-3 inhibitors: effect of a reducing agent on identified hit chemotypesIlya Okun, Sergei Malarchuk, Elena Dubrovskaya, et al.
Journal of Chemical Information and Computer Sciences|November 26, 2002
Property-based design of GPCR-targeted libraryKonstantin V Balakin, Sergey E Tkachenko, Stanley A Lang, et al.
Journal of Alzheimer'S Disease : JAD|May 28, 2017
AVN-492, A Novel Highly Selective 5-HT6R Antagonist: Preclinical EvaluationAlexandre V Ivachtchenko, Ilya Okun, Vladimir Aladinskiy, et al.
Current Drug Discovery Technologies|February 14, 2006
Efficient optimization strategy for marginal hits active against abl tyrosine kinasesSergey E Tkachenko, Ilya Okun, Konstantin V Balakin, et al.
Bioorganic & Medicinal Chemistry|February 1, 2011
Synthesis and SAR of 3-arylsulfonyl-pyrazolo[1,5-a]pyrimidines as potent serotonin 5-HT6 receptor antagonistsAlexandre V Ivachtchenko, Elena S Golovina, Madina G Kadieva, et al.
Bioorganic & Medicinal Chemistry Letters|June 6, 2012
Antagonists of 5-HT₆ receptors. Substituted 3-(phenylsulfonyl)pyrazolo[1,5-a]pyrido[3,4-e]pyrimidines and 3-(phenylsulfonyl)pyrazolo[1,5-a]pyrido[4,3-d]pyrimidines-Synthesis and 'structure-activity' relationshipAlexandre V Ivachtchenko, Elena S Golovina, Madina G Kadieva, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Journal of Alzheimer'S Disease : JAD|May 28, 2016
AVN-101: A Multi-Target Drug Candidate for the Treatment of CNS DisordersAlexandre V Ivachtchenko, Yan Lavrovsky, Ilya Okun
Journal of Biomolecular Screening|July 5, 2002
Serotonin antagonist profiling on 5HT2A and 5HT2C receptors by nonequilibrium intracellular calcium response using an automated flow-through fluorescence analysis system, HT-PS 100Gregory Kaler, Michael Otto, Alex Okun, et al.
Anti-Cancer Agents in Medicinal Chemistry|April 9, 2008
Caspase activity modulators as anticancer agentsIlya Okun, Konstantin V Balakin, Sergey E Tkachenko, et al.
Bioorganic & Medicinal Chemistry|June 22, 2013
Synthesis of substituted diphenyl sulfones and their structure-activity relationship with the antagonism of 5-НТ6 receptorsAlexandre Ivachtchenko, Elena Golovina, Madina Kadieva, et al.
Journal of Biomolecular Screening|July 18, 2006
Screening for caspase-3 inhibitors: effect of a reducing agent on identified hit chemotypesIlya Okun, Sergei Malarchuk, Elena Dubrovskaya, et al.
Journal of Chemical Information and Computer Sciences|November 26, 2002
Property-based design of GPCR-targeted libraryKonstantin V Balakin, Sergey E Tkachenko, Stanley A Lang, et al.
Journal of Alzheimer'S Disease : JAD|May 28, 2017
AVN-492, A Novel Highly Selective 5-HT6R Antagonist: Preclinical EvaluationAlexandre V Ivachtchenko, Ilya Okun, Vladimir Aladinskiy, et al.
Current Drug Discovery Technologies|February 14, 2006
Efficient optimization strategy for marginal hits active against abl tyrosine kinasesSergey E Tkachenko, Ilya Okun, Konstantin V Balakin, et al.
Bioorganic & Medicinal Chemistry|February 1, 2011
Synthesis and SAR of 3-arylsulfonyl-pyrazolo[1,5-a]pyrimidines as potent serotonin 5-HT6 receptor antagonistsAlexandre V Ivachtchenko, Elena S Golovina, Madina G Kadieva, et al.
Bioorganic & Medicinal Chemistry Letters|June 6, 2012
Antagonists of 5-HT₆ receptors. Substituted 3-(phenylsulfonyl)pyrazolo[1,5-a]pyrido[3,4-e]pyrimidines and 3-(phenylsulfonyl)pyrazolo[1,5-a]pyrido[4,3-d]pyrimidines-Synthesis and 'structure-activity' relationshipAlexandre V Ivachtchenko, Elena S Golovina, Madina G Kadieva, et al.
Pageof 2